author-photo

Deborah Hurst

Genentech

11

Papers

308

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Pharmacokinetics (PK) and pharmacodynamics (PD) of rituximab administered by faster infusion in patients with previously untreated diffuse large B-cell (DLBCL) or follicular lymphoma (FL).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma

2014 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (13)
Real-World Outcomes Among Elderly Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Final Results of a Single Arm Phase III Multicenter, Open-Label Study of Rituximab Administered by Faster Infusion in Patients with Previously Untreated Diffuse Large-B Cell (DLBCL) or Follicular Non-Hodgkin's Lymphoma (FL)

2011 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Assessment of Minimal Residual Disease (MRD) In Relapsed CLL Patients Treated with Fludarabine and Cyclophosphamide with or without Rituximab (REACH)

2010 Blood
Show All
- Source
- Cite
- Save
Citations (1)